➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
AstraZeneca
Moodys
Mallinckrodt
Colorcon

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Tauroursodeoxycholic acid


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Tauroursodeoxycholic acid?

Tauroursodeoxycholic acid is an investigational drug.

There have been 22 clinical trials for Tauroursodeoxycholic acid. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2012.

The most common disease conditions in clinical trials are Sclerosis, Amyloidosis, and Motor Neuron Disease. The leading clinical trial sponsors are Washington University School of Medicine, Beijing Trendful Kangjian Medical Information Consulting Limited Company, and IRCCS Policlinico S. Matteo.

There are three hundred and thirty-eight US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Tauroursodeoxycholic acid
TitleSponsorPhase
The Clinical Application of Tauroursodeoxycholic Acid in Patients With Liver Fibrosis.The First Affiliated Hospital with Nanjing Medical UniversityEarly Phase 1
Targeting ER Stress in Vascular DysfunctionColorado State UniversityEarly Phase 1
TUDCA as a Therapy for Ulcerative Colitis (UC)Crohn's and Colitis FoundationPhase 1

See all Tauroursodeoxycholic acid clinical trials

Clinical Trial Summary for Tauroursodeoxycholic acid

Top disease conditions for Tauroursodeoxycholic acid
Top clinical trial sponsors for Tauroursodeoxycholic acid

See all Tauroursodeoxycholic acid clinical trials

US Patents for Tauroursodeoxycholic acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tauroursodeoxycholic acid   Get Started Free Measurement method for human pancreatic lipase activity ASAHI KASEI PHARMA CORPORATION (Tokyo, JP)   Get Started Free
Tauroursodeoxycholic acid   Get Started Free 17-hydroxyprogesterone ester-containing oral compositions and related methods Lipocine Inc. (Salt Lake City, UT)   Get Started Free
Tauroursodeoxycholic acid   Get Started Free Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and use Vivus, Inc. (Campbell, CA)   Get Started Free
Tauroursodeoxycholic acid   Get Started Free Animal model of nash-induced hepatocellular carcinoma and methods for developing specific therapeutics The Regents of the University of California (Oakland, CA)   Get Started Free
Tauroursodeoxycholic acid   Get Started Free Methods and systems for determining autism spectrum disorder risk Laboratory Corporation of America Holdings (Burlington, NC)   Get Started Free
Tauroursodeoxycholic acid   Get Started Free Therapy for transthyretin-associated amyloidosis SOM Innovation Biotech, S.L. (Barcelona, ES)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Tauroursodeoxycholic acid

Drugname Country Document Number Estimated Expiration Related US Patent
Tauroursodeoxycholic acid China CN105164273 2033-04-18   Get Started Free
Tauroursodeoxycholic acid European Patent Office EP2987867 2033-04-18   Get Started Free
Tauroursodeoxycholic acid Spain ES2654437 2033-04-18   Get Started Free
Tauroursodeoxycholic acid Japan JP6064041 2033-04-18   Get Started Free
Tauroursodeoxycholic acid Japan JPWO2014171505 2033-04-18   Get Started Free
Tauroursodeoxycholic acid South Korea KR101811930 2033-04-18   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Medtronic
Dow
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.